On the 15Jan show of Moneylife, Chuck Jaffe’s guest was David Brown of Sabrient Systems – sabrientsystems.com. Each year they present Sabrient Baker’s Dozen which has outperformed the market every year it has been presented – 6 years. The current list can be review at http://www.ftportfolios.com/retail/dp/dpsummary.aspx?fundid=10624. That URL is really an information sheet for the unit invest trust – FNHTMX – which has extra charges. The dozen, tracked at http://www.dark-liquidity.com/SabrientSystems.php gained 22% last year. One of their 2014 dozen lost 46% and one gained 116%. If I were to invest in some of the dozen, I would just follow all 13 and buy that which is going up the most.
As some of you pointed out I made a slight error in my quote for for SHealthCare last week. Thank you for noticing the error.
IBD TBP’s Current Outlook is “Uptrend Under Pressure” – Not a Time to invest. The Outlook declined to it’s current level after the market decline on Wed.
My current investments:
SPharmaceuticals has a price of 21.79, a sell price 21.06, a rank of 07, and is a Hold.
SBiotechnology has a price of 235.85, a sell price 224.06, a rank of 01, and is a Hold.
SHealthCare has a price of 222.20 a sell price 215.88, a rank of 04, and is a Hold.
STransportation has a price of 90.38, a sell price 91.54, and is a sell.
SAirTransportation has a price of 71.63, a sell price 70.64, a rank of 09, and is a Hold.
My portfolio changes this weekend:
IRA #1 – None
IRA #2 – Sell STransportation
My portfolio market exposure after this weekend’s changes:
IRA #1 – 100% invested
IRA #2 – 80% invested